01 Industry overview
The durable medical equipment industry at a glance
The global durable medical equipment market was valued at $246.0 billion in 2025 and is expanding as aging populations, chronic disease and home-based care increase demand.
- $246.0B[56]
- Global market size, 2025
- 5.5%[56]
- Forecast CAGR, 2026–2033
- 36.3%[56]
- North America share, 2025
- $9.1B[57]
- Medicare DMEPOS spending, 2024
- Market size
- The global durable medical equipment market was valued at $246.0 billion in 2025 and is estimated at $260.8 billion for 2026. In the United States, retail spending on durable medical equipment reached $86.4 billion in 2024, up 5.4% from 2023.[56][28]
- Forecast & CAGR
- The global market is projected to reach $379.8 billion by 2033, representing a 5.5% compound annual growth rate from 2026 to 2033. A separate October 2026 estimate projects the market to reach $486.34 billion by 2035 at a 6.2% CAGR from 2026 to 2035, reflecting differences in market definitions and methodology.[56][19]
- Market share & regions
- North America accounted for 36.3% of global durable medical equipment revenue in 2025 and was the largest regional market. Asia-Pacific was identified as the fastest-growing region in a 2026 market estimate.[56][19]
- Segmentation
- Monitoring and therapeutic devices represented 89.5% of global revenue by product in 2025, while hospitals accounted for 34.1% by end use. Other reported end-use categories include nursing homes and home healthcare, and product categories include personal mobility devices, bathroom safety devices and medical furniture.[56]
- Key players & concentration
- The market remains fragmented: the five leading companies identified in a 2026 estimate—Medline Industries, Drive DeVilbiss Healthcare, Invacare, ResMed and Philips Respironics—collectively held 10.5% of the market in 2025. Medline Industries was the largest individual player with more than 3.5% share.[19]
- Pricing
- For most Medicare DMEPOS items, Medicare pays 80% of the lower of the supplier’s actual charge or the applicable fee-schedule amount, while the beneficiary generally pays the remaining 20% plus any unmet Part B deductible. Under competitive bidding, suppliers accept a single payment amount and Medicare pays 80% of that amount.[28]
- Trends, drivers & challenges
- Growth is being supported by population aging, chronic disease and demand for home-based care, while connected and lightweight devices are improving convenience. Key industry challenges include reimbursement pressure, supplier access requirements, fraud and waste controls, and the administrative burden of Medicare bidding and documentation.[56][28]
- Consumer behavior & competition
- Original Medicare Part B data show that 28.4 million beneficiaries used physician/DME services in 2024, with $132.7 billion in combined program payments. Competition is shaped by supplier enrollment, physician referrals, medical-necessity documentation and the ability to deliver, install and train users on equipment.[58]
- M&A
- M&A activity continued in specialized equipment and post-acute care: Direct Healthcare Group, a provider of pressure-ulcer prevention and patient-handling devices, was acquired by Rhône Group on February 2, 2026. In the broader home medical supply market, Cardinal Health completed its acquisition of ADS, a diabetes medical-supplies provider, for approximately $1.0 billion in April 2025.[59][60]
- Regulation
- The FDA’s Quality Management System Regulation became effective on February 2, 2026, incorporating ISO 13485:2016 into the medical-device quality framework and replacing the prior device inspection process. Medicare coverage generally requires a qualified provider prescription, documented medical necessity and use in the beneficiary’s home.[61][28]
- Latest news
- CMS is preparing Round 2028 of the DMEPOS Competitive Bidding Program. The next round covers continuous glucose monitors and insulin pumps, urological and ostomy supplies, hydrophilic urinary catheters, and several brace categories; contracts and single payment amounts are targeted to take effect no later than January 1, 2028.[28]
02 Ranking
Top 10 Companies in the Durable Medical Equipment Industry
The leading companies in the durable medical equipment industry, ranked on market impact, performance, momentum, innovation and brand popularity.
Updated November 11, 2026 · Next review December 11, 2026
Medline leads Gitnux's 2026 durable medical equipment ranking with an Overall score of 9.7, with more than 3.5% market share and 11.5% revenue growth. Medtronic is the highest-ranked patient monitoring and medical equipment maker at 9.6, with 8.4% revenue growth, 17.8% operating margin, and 7.9% R&D of revenue.
Ranked by Overall score · How we score ↓
Editor's top 3 picks
Where to start, by need.
#1 Overall · Leader in DME home-care distribution
Medline
US
Ranked #1 · 9.7 · DME home-care distribution
Why we picked it: It manufactures and distributes wheelchairs and other home-care equipment across DME and medical-surgical products.
Leader in patient monitoring devices
Medtronic
IE
Ranked #2 · 9.6 · Patient monitoring devices
Why we picked it: It operates in patient monitoring and medical devices, with metrics including 17.8% operating margin.
Leader in acute and emergency equipment
Stryker
US
Ranked #3 · 9.4 · Acute and emergency equipment
Why we picked it: It supplies acute-care, emergency-care and smart patient-care equipment worldwide, supported by 19.5% margin.
Pick 1 is the #1 company overall. Picks 2 and 3 are the highest-ranked companies in the top 5 that add a new segment.
Full ranking
| # | Company | Overall ↓ | Impact | Company snapshot |
|---|---|---|---|---|
| 1 | Medline DME home-care distribution · US | 9.7 | 9.9 | |
Company snapshot · Medline · Data as of November 11, 2026 Medline manufactures and distributes medical products including wheelchairs and other home-care equipment.[41]
| ||||
| 2 | Medtronic Patient monitoring devices · IE | 9.6 | 9.7 | |
Company snapshot · Medtronic · Data as of November 11, 2026 Medtronic is identified among major durable medical equipment market participants.[62]
| ||||
| 3 | Stryker Acute and emergency equipment · US | 9.4 | 9.3 | |
Company snapshot · Stryker · Data as of November 11, 2026 Stryker supplies acute-care, emergency-care and smart patient-care equipment worldwide.[39]
| ||||
| 4 | ResMed Sleep and respiratory systems · US | 9.2 | 9.0 | |
Company snapshot · ResMed · Data as of November 11, 2026 ResMed sells connected devices and masks for sleep apnea and chronic respiratory conditions.[63]
| ||||
| 5 | GE HealthCare Patient monitoring devices · US | 9.0 | 9.8 | |
Company snapshot · GE HealthCare · Data as of November 11, 2026 GE HealthCare has a large installed base of medical equipment and patient-monitoring systems.[64]
| ||||
| 6 | Sunrise Medical Manual and powered mobility equipment · DE | 8.5 | 8.7 | |
Company snapshot · Sunrise Medical · Data as of November 11, 2026 Sunrise Medical designs and manufactures manual and powered wheelchairs and seating systems.[65]
| ||||
| 7 | Arjo Patient handling, beds and mobility equipment · SE | 8.4 | 8.1 | |
Company snapshot · Arjo · Data as of November 11, 2026 Arjo makes patient-handling systems, medical beds, hygiene equipment and pressure-injury solutions.[66]
| ||||
| 8 | Drive DeVilbiss Healthcare Mobility, respiratory and daily-living equipment · US | 8.2 | 7.6 | |
Company snapshot · Drive DeVilbiss Healthcare · Data as of November 11, 2026 Drive DeVilbiss manufactures more than 3,500 DME products across mobility, beds and respiratory care.[67]
| ||||
| 9 | Invacare Mobility, beds and home-care equipment · US | 8.2 | 7.6 | |
Company snapshot · Invacare · Data as of November 11, 2026 Invacare remains an active company producing non-acute medical equipment and mobility products.[68]
| ||||
| 10 | Inogen Portable oxygen concentrators and respiratory DME · US | 8.0 | 7.0 | |
Company snapshot · Inogen · Data as of November 11, 2026 Inogen manufactures and rents portable oxygen concentrators and other respiratory products for home care.[69]
| ||||
How we score
- Impact (30%): scale and weight in the market (revenue, market share, employees, market position).
Popularity (brand search demand, 15%) counts toward Overall but is not published as a column. Overall leaves out what is not known.
Scale Scores are shown on a 7–10 scale with one decimal; bars start at 7.0.
Cadence Recalculated when new figures are published; next review December 11, 2026.
Independence. Rankings are editorially independent. Scores, ranks, picks and the verdict follow the method above; no company can pay to change them.
Cite this ranking
APA
David Kowalski. (2026, February 13). Top 10 companies in the durable medical equipment industry. In Durable Medical Equipment Industry Statistics. Gitnux. https://gitnux.org/durable-medical-equipment-industry-statistics/#top-companies
Revenue of the largest durable medical equipment companies
Medtronic leads with $36.4B in annual revenue (group level, converted to USD).
03 Trends & forecasts
Top 10 Durable Medical Equipment Industry Trends & Forecasts 2027
What is changing in the durable medical equipment industry, with the evidence behind each trend and a forecast for 2027.
Forecasts were generated by an AI model from the cited evidence. They are estimates, not guarantees.
01Older populations expand equipment demand
High confidenceThe global share of people aged 65 and older is projected to rise from 10.5% in 2025 to 19.6% by 2060. In the United States, the 65-and-older population reached 61.2 million in 2024, up 3.1% from 2023.[70]
Forecast 2027: In 2027, aging will continue to support demand for mobility equipment, respiratory devices, bathroom safety products and home medical furniture. Growth should be strongest in products that help older adults remain independent at home.
02Chronic disease broadens recurring demand
High confidenceIn 2023, 76.4% of U.S. adults, representing more than 194 million people, reported at least one selected chronic condition, while 51.4% reported multiple chronic conditions. Among adults aged 65 and older, 93.0% reported at least one condition and 78.8% reported multiple conditions.[71]
Forecast 2027: In 2027, recurring demand should remain strong for glucose-monitoring, respiratory, sleep-therapy and cardiac-monitoring equipment. Suppliers serving multiple-condition patients should benefit from higher replacement and consumables volumes.
03Home-based care gains share
High confidenceOriginal Medicare recorded 1.6 million Part B beneficiaries receiving home-health agency services in 2024, with $10.0 billion in program payments. The American Hospital Association describes hospital-at-home care as an emerging model that delivers acute-level care in patients’ homes.[58][34]
Forecast 2027: In 2027, home-based care will keep shifting equipment purchasing toward portable, easy-to-install and remotely supported products. Providers that can deliver, train users and service equipment at home should gain share over purely transactional distributors.
04Overall market growth remains moderate
Medium confidenceOne 2026 market estimate values the global durable medical equipment market at $246.0 billion in 2025 and projects $260.8 billion in 2026, reaching $379.8 billion by 2033 at a 5.5% CAGR. The same estimate places North America at 36.3% of 2025 revenue.[56]
Forecast 2027: Using the cited 5.5% growth path as the base case, global market revenue would approach $275 billion in 2027. Actual growth will vary with product scope, reimbursement conditions and the pace of home-care adoption.
05U.S. spending grows but moderates
High confidenceU.S. retail spending on durable medical equipment increased 5.4% in 2024 to $86.4 billion, following 5.8% growth in 2023. CMS reported that private insurance and out-of-pocket spending accelerated slightly, while Medicare and Medicaid growth slowed.[28]
Forecast 2027: In 2027, U.S. DME spending should continue expanding at a mid-single-digit nominal rate, supported by utilization and replacement demand but constrained by payer pressure and affordability concerns.
06Monitoring devices remain dominant
Medium confidenceMonitoring and therapeutic devices accounted for 89.5% of global durable medical equipment revenue in 2025 in one market estimate. Hospitals represented 34.1% of end-use revenue, while home healthcare was also identified as a major application.[56]
Forecast 2027: In 2027, monitoring and therapeutic products should continue to outgrow basic equipment as diabetes, respiratory and cardiovascular management move toward continuous or repeated measurement. Hospital demand will remain material, but home-use monitoring should take incremental share.
07Connected devices require stronger cyber controls
High confidenceThe FDA issued updated medical-device cybersecurity guidance on June 27, 2025. For devices covered by the cyber-device provisions of the FD&C Act, manufacturers must include plans to monitor, identify and address postmarket cybersecurity vulnerabilities.[61]
Forecast 2027: By 2027, connected DME suppliers and manufacturers will increasingly compete on secure software updates, vulnerability response and interoperability, not only on hardware price. Cybersecurity documentation will become a more routine part of procurement and contracting.
08Quality compliance costs rise after QMSR
High confidenceThe FDA’s Quality Management System Regulation became effective on February 2, 2026, incorporating ISO 13485:2016 into 21 CFR Part 820 and replacing the prior inspection approach. The rule applies to finished-device manufacturers intending to commercially distribute medical devices.[61]
Forecast 2027: In 2027, manufacturers and private-label suppliers should face higher documentation, audit and quality-system costs. Larger firms will be better positioned to absorb compliance spending, potentially encouraging outsourcing or consolidation among smaller producers.
09Competitive bidding returns nationwide
High confidenceCMS plans Round 2028 as a nationwide remote-item-delivery competitive bidding program beginning no later than January 1, 2028. The round covers seven categories, including CGMs and insulin pumps, urological supplies, ostomy supplies, hydrophilic urinary catheters and off-the-shelf braces.[28]
Forecast 2027: During 2027, suppliers will devote more resources to registration, bid preparation, documentation and nationwide delivery capabilities. The program should intensify price competition and favor suppliers with scale, logistics coverage and reliable beneficiary service.
10Payment models shift toward bundled rentals
High confidenceStarting January 1, 2028, CMS will pay for most rented CGMs and insulin pumps, including necessary supplies and accessories, through bundled monthly rental payments. Suppliers will retain ownership of the rental equipment, while insulin remains separately paid.[28]
Forecast 2027: In 2027, suppliers will redesign billing, inventory and customer-service processes ahead of the bundled model. Recurring revenue and equipment-retention economics should become more important than one-time device sales in covered diabetes categories.
04 Statistics
Technology & Innovation
Digital transformation and data systems show mixed adoption across medtech, with 29% meeting digital targets in 2021 and 36% showing limited value. For durable medical equipment, connected device expectations raise the bar for implementation.
Digital Transformation in the medical devices sector (sector benchmark)
- Across medtech companies, 29% met or exceeded their digital-transformation targets with sustainable change in 2021, according to BCG’s global survey.[1]
- Across medtech manufacturing executives, 64% highly prioritized digitizing manufacturing in a 2022 survey.[2]
- Across medtech companies, 36% achieved limited value and no sustainable change from digital transformation in 2021.[1]
- Across medtech and IVD professionals worldwide, 89% said their company had implemented or planned to implement AI or digital solutions in its product range in 2020.[3]
- Across medtech companies, 35% created value but failed to meet all digital-transformation targets in 2021.[1]
- Across medtech and IVD professionals worldwide, 87% said their company had implemented or planned to implement AI or digital solutions in regulatory or quality-management systems in 2020.[3]
Technology Adoption in the medical devices sector (sector benchmark)
- Across healthcare industrial-ecosystem SMEs in Europe, 31.0% already used cloud technologies in 2023.[4]
- Across healthcare industrial-ecosystem SMEs in Europe, 8.6% already used remote patient-monitoring technologies in 2023.[4]
- Among emerging medtech companies, 38% had adopted clinical-trial-management systems, compared with 72% of enterprise and global companies in the 2025 benchmark.[5]
- Across healthcare industrial-ecosystem SMEs in Europe, 17.3% already used robotics in 2023.[4]
- Across healthcare industrial-ecosystem SMEs in Europe, 13.7% already used artificial intelligence in 2023.[4]
- Among emerging medtech companies, 62% had adopted electronic trial-master-file systems, compared with 89% of enterprise and global companies in the 2025 benchmark.[5]
Cloud Computing in the medical devices sector (sector benchmark)
- Across surveyed medtech organizations, 31% managed all postmarket-surveillance processes with cloud-based technology in 2025.[5]
- Across surveyed medtech organizations, 33% reported reliable enterprise-wide use of cloud-based technologies in 2025.[5]
- Across medical-device manufacturing respondents in the global Industry Cloud Study, 66% reported that 50%–74% of infrastructure was in the cloud in 2022.[6]
- Across medical-device manufacturing respondents in the global Industry Cloud Study, 21% reported that 75%–100% of infrastructure was in the cloud in 2022.[6]
Big Data in the medical devices sector (sector benchmark)
- 59% of medtech strategy and finance leaders prioritized advanced analytics for revenue management, compared with 57% for GenAI and 32% for AI/ML, in 2025.[7]
- Across medtech and biopharma companies surveyed in 2018, 67% of medtech firms invested in data analytics for reporting.[8]
- 45% was the average share of planned digital-enabler spending that medtech companies allocated to infrastructure, cloud enablement, architecture modernization, and AI and big data, globally, in 2021.[1]
- 15.3% of SMEs in Europe’s healthcare industrial ecosystem had adopted big data and related data analytics, according to the 2023 EMI survey.[4]
- Across healthcare industrial-ecosystem SMEs in Europe, 15.3% had adopted big data and related data analytics in 2023.[4]
- 80% of medtech companies planned to invest in infrastructure, cloud enablement, tech-architecture modernization, and AI and big data, based on a 2021 global survey.[1]
IoT in the medical devices sector (sector benchmark)
- Among European healthcare industrial-ecosystem SMEs already using IoT, 21.4% used predictive maintenance for production assets in 2023.[4]
- Among healthcare and medical-device IoT respondents, 9% had deployed between 10,001 and 100,000 connected devices in 2023.[9]
- Across healthcare industrial-ecosystem SMEs in Europe, 20.4% already used Internet of Things technologies in 2023.[4]
- Among European healthcare industrial-ecosystem SMEs already using IoT, 22.3% used energy-saving devices such as smart lighting, HVAC or elevators in 2023.[4]
- Among healthcare and medical-device IoT respondents, 84% planned to increase their connected-device estate in 2023.[10]
- Among healthcare and medical-device IoT respondents, 31% planned to double the number of connected devices deployed in 2023.[10]
Innovation in the durable medical equipment industry
- 25% fewer manufacturers entered durable medical equipment markets affected by Medicare price reductions in the United States, 2023.[11]
- 22% fewer new durable medical equipment models were introduced in categories affected by Medicare price reductions than in unaffected categories in the United States, 2023.[11]
05 Statistics
Data & Analytics
Service and data operations emphasize measurable throughput outcomes, including first-visit resolution at 83% for top teams versus 56% for the bottom 20%. Benchmarking links analytics to faster issue closure.
Business intelligence in the durable medical equipment industry
- The medical-device service benchmark covered $3.4 billion in service costs across the analyzed asset and service-event dataset.[12]
- Aquant identified a fivefold difference in issue-resolution speed between high-performing medical-device service teams and the bottom 20%.[12]
- More than 9 million medical-device service events and 1.5 million assets were analyzed in Aquant’s 2025 service benchmark.[12]
- AdaptHealth reported approximately 11,000 employees, including approximately 1,000 healthcare professionals, in 2023.[13]
- AdaptHealth reported more than 1 million connected devices provided to patients in its 2023 discussion of data collection opportunities.[13]
Data analytics in the durable medical equipment industry
- AdaptHealth reported more than 300,000 chronic-respiratory-condition patients with whom it interacted regularly in 2023.[13]
- AdaptHealth reported more than 1.5 million obstructive-sleep-apnea patients with whom it interacted regularly and could support adherence data collection in 2023.[13]
- AdaptHealth reported more than 230,000 diabetes patients with whom it interacted regularly in 2023, including patients using connected devices.[13]
Data Quality in the medical devices sector (sector benchmark)
- 60% of medical-device professionals using literature-review software reported data traceability, compared with 4% using spreadsheets, in a global survey; survey year not stated.[14]
- 73% of medical-device professionals using literature-review software trusted their data quality, compared with 38% using spreadsheets, in a global survey; survey year not stated.[14]
- 56% of medical-device companies used non-validated general-purpose tools for clinical data collection in the 2024 MedTech industry survey.[15]
- 51% of medical-device companies still managed postmarket-surveillance processes and data manually or partially manually in the 2025 benchmark survey.[5]
- 45.9% of healthcare-sector business partners identified data quality as a major challenge in managing digital product information in the 2021 survey.[16]
Data Governance in the medical devices sector (sector benchmark)
- More than 72% of healthcare-sector business partners had not established a product-master-data system reflecting data governance in the 2021 survey.[16]
- 31.4% of healthcare-sector business partners had a digital-asset-management system for storing images and product data sheets in the 2021 survey.[16]
- 62.3% of healthcare-sector business partners identified creating a central data master as a single source of truth as the greatest digital-product-information challenge in 2021.[16]
- More than 30% of healthcare-sector business partners had no clear formal data-governance guidelines in the 2021 survey.[16]
KPIs in the durable medical equipment industry
- The best medical-device service teams achieved an 83% first-visit resolution rate in Aquant’s 2025 benchmark.[12]
- Bottom-performing medical-device service teams achieved a 56% first-visit resolution rate in Aquant’s 2025 benchmark.[12]
- High-performing medical-device service teams resolved issues five times faster than the bottom 20% in Aquant’s 2025 benchmark.[12]
- Viemed’s unique patient base increased 10% in 2024, while total resupply setups or deliveries increased 13%.[17]
06 Statistics
Strategy & Growth
Market trajectory is moderate, with the global durable medical equipment market estimated at $260.8 billion for 2026 and a 5.5% CAGR projected for 2026–2033. Regional demand is concentrated in North America at 36.3% in 2025.
Growth in the durable medical equipment industry
- $112.519 billion is the projected United States durable-medical-equipment market size for 2030.[18]
- 5.95% is the projected annual growth rate of the United States durable-medical-equipment market for 2025–2030.[18]
- 4.63% was the estimated year-over-year growth of the United States durable-medical-equipment market in 2024.[18]
- $79.5 billion was the estimated United States durable-medical-equipment market size in 2024.[18]
- $253.70 billion was the estimated global durable-medical-equipment market revenue in 2024.[19]
Differentiation in the durable medical equipment industry
- 63% of AdaptHealth’s net revenue came from resupply and one-time-sale products in 2025, indicating a recurring-product differentiation strategy, United States.[13]
- Approximately 4.3 million patients were served annually by AdaptHealth’s patient-centered healthcare-at-home model in 2025, United States.[13]
- Four reportable segments—Sleep Health, Respiratory Health, Diabetes Health and Wellness at Home—made up AdaptHealth’s operating model in 2025, United States.[13]
Mergers and acquisitions in the durable medical equipment industry
- $0.3 million in deferred consideration was recorded for AdaptHealth’s 2025 acquisitions, United States.[13]
- $9.5 million in cash consideration was paid by AdaptHealth for a home-medical-equipment acquisition in 2024, United States.[13]
- $42.8 million in cash consideration was paid by AdaptHealth for its 2025 home-medical-equipment acquisitions, United States.[13]
- Five home-medical-equipment providers were acquired by AdaptHealth in 2025: assets of four providers and equity interests in one provider, United States.[13]
07 Statistics
People & Workforce
Workforce patterns include remote and hybrid operations, with remote employees averaging 41.5 hours per week in 2023. Compensation and quality-process challenges affect adoption of documentation and traceability practices.
Remote Work in the medical devices sector (sector benchmark)
- Remote medical device and diagnostics professionals reported a median 4% pay increase in 2023, according to an industry salary survey.[20]
- Remote medical device and diagnostics employees worked an average of 41.5 hours per week in 2023, compared with 43 hours for office-based employees.[20]
- Remote medical device and diagnostics professionals reported a median salary of $142,000 in 2023, according to an industry salary survey.[20]
- About 50% of medical device and diagnostics professionals worked fully remotely in 2023, based on 226 usable survey responses in the United States.[20]
Hybrid Work in the medical devices sector (sector benchmark)
- Hybrid medical device and diagnostics professionals represented about 40% of respondents in MD+DI’s 2023 salary survey, covering 226 usable responses.[20]
- Hybrid medical device and diagnostics professionals reported a median 4% pay increase in 2023, according to an industry salary survey.[20]
- Hybrid medical device and diagnostics professionals reported a median salary of $135,000 in 2023, according to an industry salary survey.[20]
- Hybrid medical device professionals reported a median salary of $150,000 in 2026, compared with $140,000 for remote and $116,000 for in-office professionals.[20]
Employee Engagement in the medical devices sector (sector benchmark)
- In medical devices, 23% of employees disagreed that their total compensation was fair relative to similar roles at other companies in the 2026 benchmark.[21]
- Medical devices organizations had a median employee net promoter score of 14 in Culture Amp’s 2026 benchmark.[21]
- In medical devices, 73% of employees were engaged in benchmark data collected from July 2025 through June 2026, predominantly across Northern America, Oceania, Europe and Asia.[21]
- In medical devices, 91% of employees agreed they understood how their work contributed to company goals in benchmark data collected through June 2026.[21]
Change Management in the medical devices sector (sector benchmark)
- Only 2% of surveyed medical device manufacturers rated their ability to estimate product-change costs as excellent, while 10% rated it poor.[22]
- Among pre-market medical device companies surveyed in 2023, 18% cited lack of management buy-in as a challenge to improving quality management processes.[15]
- Among pre-market medical device companies surveyed in 2023, 25% cited resistance to change efforts as a quality-management challenge.[15]
- Among post-market medical device companies surveyed in 2023, 23% cited lack of management buy-in as a challenge to improving quality management processes.[15]
- Among post-market medical device companies surveyed in 2023, 37% cited resistance to change efforts as a challenge to improving quality management processes.[15]
08 Statistics
Customer & Sales
User experience signals concentrate around delivery and equipment quality, with 69% rating delivery timeliness as very positive in 2023 and 75% rating equipment quality as very positive. These drivers connect to supplier performance expectations.
Customer experience in the durable medical equipment industry
- 64% of U.S. respondents familiar with DME rated driver or technician care as a very positive experience in 2023.[23]
- 69% of U.S. respondents familiar with DME rated delivery timeliness as a very positive experience in 2023.[23]
- 75% of U.S. respondents familiar with DME rated equipment quality as a very positive experience in 2023.[23]
- 89% of beneficiaries in U.S. competitive-bidding areas rated their initial DME supplier interaction good or very good in 2011.[24]
- 65% of U.S. respondents familiar with DME rated driver or technician knowledge as a very positive experience in 2023.[23]
Customer acquisition in the durable medical equipment industry
- AdaptHealth’s Diabetes Health revenue decreased $22.0 million, or 3.6%, in 2025 despite growth in insulin-pump and supply patient census.[13]
- AdaptHealth’s Sleep Health revenue increased $28.9 million, or 2.1%, in 2025, primarily from higher patient census in PAP resupply products.[13]
- AdaptHealth’s organic revenue increased $56.857 million, or 1.7%, in 2025 versus 2024.[13]
- AdaptHealth served more than 4.5 million patients across approximately 670 locations in 48 U.S. states in 2025.[13]
- AdaptHealth entered nearly 40,000 U.S. homes each day in 2025.[13]
09 Statistics
Marketing & Brand
Influencer activity is high in healthcare, with 8.57 million influencer posts globally in 2023. In 2026, 50% of healthcare and pharmaceutical marketers report dedicated, growing budgets for creator or influencer marketing.
Influencer Marketing in the medical devices sector (sector benchmark)
- 8.57 million influencer posts about the health industry were published globally in 2023, across the platforms measured by Sprout Social.[25]
- 50% of healthcare and pharmaceutical marketers had dedicated, growing budgets for creator or influencer marketing in 2026.[26]
- 10% of healthcare and pharmaceutical marketers reported that they did not invest in creator or influencer marketing in 2026.[26]
- 8% of healthcare and pharmaceutical marketers had dedicated but shrinking budgets for creator or influencer marketing in 2026.[26]
- 29% of healthcare and pharmaceutical marketers had dedicated but flat budgets for creator or influencer marketing in 2026.[26]
10 Statistics
Operations & Execution
Operational compliance shows persistent documentation risk, including that three of the ten frequently cited ACHC DMEPOS deficiencies in 2025 concerned information provided to clients or patients. CMS also consolidated bidding IT into one portal, Connexion.
Process optimization in the durable medical equipment industry
- Rotech maintained more than 3,000 payer plans spanning national, regional and local payers in 2024.[13]
- AdaptHealth reported 327,300 myApp users in the fourth quarter of 2025, more than double the comparable 2024 level.[27]
- Rotech served more than 1 million active home-healthcare patients at December 31, 2024.[13]
- AdaptHealth’s Sleep Health segment generated $1.378 billion in 2025 net revenue, the company’s largest reported segment.[13]
- CMS consolidated DMEPOS competitive-bidding information technology systems into one portal, Connexion, for the Round 2028 process in 2025.[28]
Operational efficiency in the durable medical equipment industry
- U.S. medical-equipment manufacturing output declined from $86.053 billion in 2024 to $82.737 billion in 2025.[29]
- Medical-equipment manufacturing sector output was $82.737 billion in the United States in 2025.[29]
- AdaptHealth’s 2025 Sleep Health adjusted EBITDA margin was 22.5%, down from 25.8% in 2024.[13]
- AdaptHealth generated $601.8 million in operating cash flow in 2025, up from $541.8 million in 2024.[27]
- AdaptHealth’s 2025 Respiratory Health adjusted EBITDA margin was 30.3%.[13]
Quality management in the durable medical equipment industry
- Three of the ten frequently cited ACHC DMEPOS deficiencies in 2025 concerned information provided to clients or patients.[30]
- Ten DMEPOS accreditation standards were cited as noncompliant in more than 15% of ACHC accreditation surveys reviewed in 2025.[30]
- The Joint Commission’s 2026 DMEPOS standards crosswalk covers CMS quality standards and elements of performance.[31]
- The most frequently cited ACHC DMEPOS standard had a 30% noncompliance rate in 2025, down from 42% in 2022.[30]
Supply chain in the durable medical equipment industry
- AdaptHealth’s 2025 Sleep Health segment incurred $445.1 million in product and supply costs.[13]
- Global medical-device trade reached $700 billion in 2022, with approximately one-third consisting of durable capital equipment.[32]
- The average annual number of reported medical-device shortages rose from five during 2010–2019 to more than 20 in the first half of 2020.[33]
- AdaptHealth’s 2025 Respiratory Health segment incurred $132.5 million in product and supply costs.[13]
- Nearly 70% of medical devices marketed in the United States were manufactured exclusively overseas, according to a 2025 industry analysis.[34]
Outsourcing / Offshoring in the medical devices sector (sector benchmark)
- 11.4% was the year-over-year growth rate of the global medtech outsourcing market in 2023.[35]
- $81.5 billion was the global medtech outsourcing market in 2023, covering contract development and manufacturing organizations (CDMOs).[35]
- More than half of 59 global medtech CDMO transactions in 2023 had cross-border characteristics.[35]
- $18.5 billion was the European medtech CDMO market in 2023.[35]
- $26.3 billion was the U.S. medtech CDMO market in 2023, after 12.9% growth from 2022.[35]
11 Statistics
Finance & Pricing
Pricing mechanics remain payer-formula dependent: Medicare generally pays 80% of the lower of actual charge or fee-schedule amount. Beneficiary responsibility is 20% plus any unmet Part B deductible.
Pricing strategy in the durable medical equipment industry
- Medicare beneficiaries are generally responsible for 20% of the applicable DMEPOS payment amount plus any unmet Part B deductible.[28]
- CMS projects approximately four national contract suppliers for off-the-shelf back braces using 2024 claims data.[28]
- Medicare pays 80% of the lower of a DMEPOS supplier’s actual charge or the applicable fee-schedule amount, before the Part B deductible.[28]
- CMS projects approximately 10 national contract suppliers for the CGM and insulin-pump category using 2024 claims data.[28]
- CMS projects approximately eight national contract suppliers for urological and ostomy supplies using 2024 claims data.[28]
Cost reduction in the durable medical equipment industry
Profitability in the durable medical equipment industry
- AdaptHealth’s 2025 Sleep Health adjusted EBITDA declined 10.9% from 2024.[13]
- AdaptHealth’s Wellness at Home segment produced $70.3 million of adjusted EBITDA in 2025.[13]
- AdaptHealth reported $90.9 million of operating income in 2025, compared with $263.7 million in 2024.[13]
- AdaptHealth reported $616.7 million in adjusted EBITDA in 2025, down from $688.7 million in 2024.[27]
- AdaptHealth’s Sleep Health segment produced $310.6 million of adjusted EBITDA in 2025.[13]
Financial planning in the durable medical equipment industry
- AdaptHealth provided 2026 financial guidance in its full-year 2025 results announcement.[27]
- AdaptHealth’s 2025 operating cash flow was $601.8 million, supporting liquidity planning for future operations.[27]
- AdaptHealth reported $250 million of debt reduction during 2025, a key balance-sheet planning measure.[27]
- AdaptHealth’s 2025 free cash flow was $219.4 million after capital and operating cash requirements.[27]
- AdaptHealth’s 2025 interest expense was $126.7 million, compared with $126.7 million in 2024.[13]
12 Statistics
Product & Service
Service performance is quantifiable, with best service teams resolving issues on the first visit 83% of the time versus 56% for bottom performers. Refurbishment and recovered product programs also scale reuse.
Product development in the durable medical equipment industry
- Medtronic reported $2.735 billion in annual R&D spending in the 2023 Medtech Big 100 analysis.[36]
- Medical device companies in the Medtech Big 100 devoted an average of 10% of revenue to R&D in fiscal 2023.[36]
- ResMed reported $287.642 million in annual R&D spending in the 2023 Medtech Big 100 analysis.[36]
- Royal Philips reported $2.041 billion in annual R&D spending in the 2023 Medtech Big 100 analysis.[36]
- $20.445 billion was spent on domestic R&D performed by U.S. medical equipment and supplies companies in 2023, equal to 4.3% of domestic sales.[37]
Product lifecycle in the durable medical equipment industry
- AdaptHealth recorded $325.696 million in patient-equipment depreciation in 2023.[13]
- AdaptHealth recorded $320.289 million in patient-equipment depreciation in 2024.[13]
- AdaptHealth recorded $341.287 million in patient-equipment depreciation in 2025, indicating the scale of its equipment lifecycle expense.[13]
- More than 11,000 Stryker products were recovered and returned to use through certified pre-owned and refurbishment programs in 2025.[38]
- Stryker’s certified pre-owned and refurbishment programs diverted more than 1.5 million pounds of material from landfills in 2025.[38]
After-sales in the durable medical equipment industry
- VieMed generated $10.665 million in service revenue in 2023.[13]
- High-performing medical-device service organizations fixed issues five times faster than the bottom 20%, a difference of 12 days.[12]
- VieMed generated $20.133 million in service revenue in 2024, up 88.8% from 2023.[13]
- The best medical-device service teams resolved issues on the first visit 83% of the time, compared with 56% for bottom performers, based on 9 million service events.[12]
Value proposition in the durable medical equipment industry
- AdaptHealth’s wellness-at-home segment generated $646.202 million in net revenue in 2024.[13]
- AdaptHealth’s respiratory-health segment generated $651.150 million in net revenue in 2024.[13]
- AdaptHealth maintained ongoing contact with more than 1.5 million people with obstructive sleep apnea in 2023.[13]
- AdaptHealth maintained ongoing contact with more than 230,000 people with diabetes in 2023.[13]
- AdaptHealth maintained ongoing contact with more than 300,000 people with chronic respiratory conditions in 2023.[13]
13 Statistics
Sustainability & Ethics
Sustainability disclosures include Medline’s 20 million-plus kWh of renewable electricity generated at facilities in 2025 and 3.4 million-plus medical devices reprocessed through its facilities in 2025. Waste and reprocessing metrics are tied to operations.
Sustainability in the durable medical equipment industry
- Stryker’s Sustainability Solutions diverted more than 5 million pounds of medical-device waste from landfills in 2024.[39]
- 20 million-plus kWh of renewable electricity was generated at Medline facilities in 2025.[40]
- 7,278,301 metric tons of CO2e were Medline’s total absolute global emissions in 2023.[40]
- 98% of Medline distribution centers were LEED-certified or pending certification in 2023.[41]
- 3.4 million-plus medical devices were reprocessed through Medline’s facilities in 2025.[40]
ESG in the durable medical equipment industry
- Medline donated 643 metric tons of medical products in 2022.[41]
- Medline’s 2023 Scope 3 emissions totaled 6,972,560 metric tons of CO2e.[40]
- Medline’s 2023 Scope 2 emissions totaled 131,904 metric tons of CO2e.[40]
- Medline’s donated products were valued at more than $2.7 million in 2022.[41]
- Medline conducted 592 social audits of its supply chain in 2022.[41]
Ethics in the durable medical equipment industry
- 849 Medicare DME supplier firms were identified as subject to anti-fraud enforcement in a 2026 research dataset.[42]
- 592 supplier social audits were completed by Medline in 2022 to support ethical sourcing.[41]
- $21 million in restitution was ordered in the 2025 Florida case involving medically unnecessary DME.[43]
- 90 months in prison was the sentence imposed on the owner of three DME companies in a 2026 Medicare-fraud case.[44]
- More than $4 billion in catheter claims were allegedly attempted by 15 providers during 2023 and 2024.[24]
CSR in the durable medical equipment industry
- 643 metric tons of medical products were donated by Medline in 2022.[41]
- $2.7 million-plus was the value of medical products Medline donated to low-resource regions and disaster-affected communities in 2022.[41]
- 125-plus countries and territories were covered by Medline’s 2022 global ESG activities.[41]
- 10 nonprofit organizations received Medline Community Impact Grants promoting health equity in 2023.[41]
- $300 million was invested by Medline in 2023 to strengthen healthcare operations, manufacturing, technology and sustainability.[41]
Circular economy in the durable medical equipment industry
- 1.1 million pounds of waste were diverted from landfill through Medline reprocessing in 2022.[41]
- More than 1 million pounds of waste were diverted from landfills by Medline ReNewal in 2020.[41]
- 365,000-plus pounds of pulse-oximeter sensors and ECG leads were recycled by Stryker in 2024.[39]
- 31% of ResMed’s collected product waste was diverted from landfill in 2024.[45]
- 2.3 million-plus medical devices were reprocessed by Medline in 2022.[41]
Carbon footprint in the durable medical equipment industry
- 6,972,560 metric tons of CO2e were Medline’s Scope 3 emissions in 2023.[40]
- 6.7% of Medline’s 2023 emissions came from end-of-life treatment.[40]
- Nearly 1,500 metric tons of carbon dioxide emissions were avoided through Medline reprocessing in 2020.[41]
- 78.0% of Medline’s 2023 emissions were associated with purchased goods and services.[40]
- 5.5% of Medline’s 2023 emissions came from upstream transportation and distribution.[40]
14 Statistics
Risk, Compliance & Legal
Compliance pressure combines fraud controls and quality requirements, including CMS payment suspensions preventing 99%+ of alleged catheter-fraud payments in 2023 and 2024. Cyber expectations also rise, with 84% of healthcare organizations including cybersecurity requirements in 2026 vendor RFPs.
Compliance in the durable medical equipment industry
- 99% plus of alleged catheter-fraud payments were prevented by CMS payment suspensions in 2023 and 2024.[24]
- 849 DME supplier firms were identified as subject to anti-fraud enforcement in research covering Medicare suppliers.[42]
- More than 7,000 unannounced site visits were conducted by CMS in 2023 for Medicare-enrolled hospices, illustrating the program’s provider-screening controls.[43]
- Six months was the nationwide CMS moratorium announced in 2026 on enrolling new DME providers.[28]
- $19,940 was the 2025 maximum civil monetary penalty for certain DME suppliers that knowingly failed to provide covered items or services.[46]
Risk Management in the medical devices sector (sector benchmark)
- More than 50% of medical device professionals said they could not document closed-loop traceability in 2024.[47]
- 35% of medical device professionals cited unclear ownership of risk across the product life cycle as a risk-management challenge in 2024.[47]
- 34% of medical device professionals cited insufficient access to appropriate information during design and development as a risk-management challenge in 2024.[47]
- 70% of medical device companies used manual documentation and spreadsheets for risk management during the design process in 2023.[48]
- 33% of medical device company leaders felt very confident in the integrity of risk-analysis data in 2023.[48]
Cybersecurity in the medical devices sector (sector benchmark)
- 84% of healthcare organizations across the United States, United Kingdom and Germany included cybersecurity requirements in medical-device vendor RFPs in 2026.[49]
- 56% of healthcare organizations across the United States, United Kingdom and Germany rejected a medical device because of cybersecurity concerns in 2026.[49]
- 28% of healthcare organizations across the United States, United Kingdom and Germany operated medical devices past end-of-support in 2026.[49]
- 80% of facilities attacked across the United States, United Kingdom and Germany reported moderate or significant patient-care impact in 2026.[49]
- 24% of facilities across the United States, United Kingdom and Germany experienced a cyberattack on a medical device in 2026.[49]
Data Privacy in the medical devices sector (sector benchmark)
- 47% of medtech respondents identified data privacy and security as a key development challenge for their companies in 2024.[50]
- 86% of medical-device stakeholders considered data security for digital health technologies extremely important in a 2023 survey.[51]
- 30% of respondents rated data security for wearable medical devices very important in 2023.[52]
- 64% of respondents rated data security for wearable medical devices extremely important in 2023.[52]
Crisis Management in the medical devices sector (sector benchmark)
- 61% of pharma, life-sciences, medtech and health organizations had conducted exercises with their crisis-management team in 2020.[53]
- 90% of pharma, life-sciences, medtech and health organizations had formulated a business-continuity-management strategy in 2020.[53]
- 89% of pharma, life-sciences, medtech and health organizations had established a crisis-management organization in 2020.[53]
- 57% of pharma, life-sciences, medtech and health organizations had pandemic planning in place in 2020.[53]
Governance in the durable medical equipment industry
- $59.9 million was involved in the 2026 case alleging kickbacks and false medical-necessity representations by DME companies.[44]
- $21 million in restitution was ordered in a 2025 case involving fraudulent Medicare payments for medically unnecessary DME.[43]
- 17 material ESG priorities were organized under Medline’s governance, environmental, product, people and community framework in 2022.[41]
- 592 supplier social audits were performed by Medline in 2022 under its responsible-sourcing oversight.[41]
- 90 months’ imprisonment was imposed on the DME-company owner convicted in the 2026 Medicare-fraud case.[44]
15 Statistics
Globalization & Expansion
International sourcing is material for durable medical equipment supply chains, with nearly 70% of medical devices marketed in the United States manufactured exclusively overseas in a 2025 industry analysis. Regional outcomes remain shaped by U.S. scale, including 36.3% of global revenue share in 2025.
Globalization in the durable medical equipment industry
- 8.7% of global medical-device exports came from the United States in 2025.[54]
- 7.1% of global medical-device exports came from Japan in 2025.[54]
- 44.0% of global medical-device exports were supplied by Germany, China, the United States and Japan combined in 2025.[54]
- 14.9% of global medical-device exports came from Germany in 2025, the largest national share.[54]
- 18.0% of global medical-device imports were accounted for by the United States in 2025, the largest national share.[54]
Supplier management in the durable medical equipment industry
- 4.2 million patients were served annually by AdaptHealth through approximately 660 locations in 47 states, United States, 2024.[13]
- Two to three suppliers typically provide each major product category purchased by AdaptHealth, including sleep therapy, mobility and home services, and diabetes products, United States, 2024.[13]
- 39,000 equipment and supply deliveries per day were completed on average by AdaptHealth in 2024, United States.[13]
Stakeholder management in the durable medical equipment industry
- 63% of AdaptHealth’s 2025 net revenue came from resupply, one-time-sale products and related home medical equipment, United States.[13]
- 4.3 million patients were served annually by AdaptHealth through approximately 640 locations in 48 states, United States, 2025.[13]
- 33% of AdaptHealth’s 2025 net revenue came from products paid through fixed monthly reimbursement amounts, United States.[13]
Distribution channels in the durable medical equipment industry
- 55.0% was the estimated home-healthcare channel share of the United States durable-medical-equipment market in 2024.[18]
- 44% of the global durable-medical-equipment market was estimated to be generated through direct sales in 2025.[55]
- 14% of the global durable-medical-equipment market was estimated to be generated through online channels in 2025.[55]
- 310 million durable-medical-equipment units were estimated to be dispensed in the United States in 2024.[18]
- $256.5 was the estimated average revenue per durable-medical-equipment unit in the United States in 2024.[18]
Key questions about the Durable Medical Equipment Industry
What is the durable medical equipment market size in 2026?
How fast is the market expected to grow after 2026?
Which companies lead the durable medical equipment industry?
What technology shifts matter for durable medical equipment in 2026?
How is the industry structured in terms of competition and concentration?
How do Medicare DMEPOS payments typically work for beneficiaries?
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
David Kowalski. (2026, February 13). Durable Medical Equipment Industry Statistics. Gitnux. https://gitnux.org/durable-medical-equipment-industry-statistics
David Kowalski. "Durable Medical Equipment Industry Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/durable-medical-equipment-industry-statistics.
David Kowalski. 2026. "Durable Medical Equipment Industry Statistics." Gitnux. https://gitnux.org/durable-medical-equipment-industry-statistics.
Sources & references
71 sources cited across this report
bcg.com
mastercontrol.com
nsf.org
monitor-industrial-ecosystems.ec.europa.eu
veeva.com
pages.awscloud.com
modeln.com
www-statista-com.libproxy.pcc.edu
eseye.com
ashb.com
scholar.harvard.edu
- discover.aquant.ai
sec.gov
distillersr.com
blog.greenlight.guru
- sana-suisse-med.ch
d2ghdaxqb194v2.cloudfront.net
kenresearch.com
gminsights.com
mddionline.com
cultureamp.com
resources.sw.siemens.com
- nphihealth.org
gao.gov
media.sproutsocial.com
- brand-news.it
- adapthealth.com
cms.gov
fred.stlouisfed.org
achc.org
jointcommission.org
oecd.org
aspe.hhs.gov
aha.org
alirahealth.com
cache.91c2be992dfb7dcc6256c04eaf0f366c.r2.cloudflarestorage.com
ncses.nsf.gov
s22.q4cdn.com
stryker.com
medline.com
newsroom.medline.com
nber.org
files.gao.gov
justice.gov
document.resmed.com
govinfo.gov
greenlight.guru
cognition.us
runsafesecurity.com
deloitte.com
mdic.org
dennemeyer.com
- 2bridge.partners
krungsri.com
- reedintelligence.com
grandviewresearch.com
medpac.gov
data.cms.gov
hl.com
oregon.gov
fda.gov
thebusinessresearchcompany.com
investor.resmed.com
gehealthcare.com
sunrisemedical.com
arjo.com
- devilbissmedical.com
- search.sunbiz.org
investor.inogen.com
cdn.www.census.gov
cdc.gov
